Associate Professor, Hematology and Medical Oncology, Emory University School of Medicine
Hematology
Dr. Elliott F. Winton, MD
|
|
Give Review
Elliott Winton works in the field of Hematology. He went to medical school at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10 in research and 19 in primary care medicine Elliott Winton has written publications. He has 83 publications published with PubMed. The lastest publication is: 'Hematologic and virologic effects of lineage-specific and non-lineage-specific recombinant human and rhesus cytokines in a cohort of SIVmac239-infected macaques.' Doctor Elliott F. Winton, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- Three-year efficacy, overall survival, and safety of ruxolitinib therapy in patients with myelofibrosis from the COMFORT-I study.
- Predicting early blast transformation in chronic-phase chronic myeloid leukemia: Is immunophenotyping the missing link?
- Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies.
- Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
- Effect of Ruxolitinib Therapy on Myelofibrosis-Related Symptoms and Other Patient-Reported Outcomes in COMFORT-I: A Randomized, Double-Blind, Placebo-Controlled Trial.
- The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosis.
- Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia.
- Long-term treatment with rituximab of autoimmune autonomic ganglionopathy in a patient with lymphoma.
- A phase I clinical-pharmacodynamic study of the farnesyltransferase inhibitor tipifarnib in combination with the proteasome inhibitor bortezomib in advanced acute leuk...
- Acquired copper deficiency: a potentially serious and preventable complication following gastric bypass surgery.
- Update on myelodysplastic syndromes: new approaches to classification and therapy.
- Update in acute leukemia 2003: a risk adapted approach to acute myeloblastic leukemia in adults.
- Use of long-term human marrow cultures to demonstrate progenitor cell precursors in marrow treated with 4-hydroperoxycyclophosphamide.
- A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.
- High incidence of veno-occlusive disease related to indicine N-oxide in the treatment of refractory adult acute leukemia.
- Autologous marrow transplantation after karyotypic conversion to normal in blastic phase of chronic myelocytic leukemia.
- Recombinant human granulocyte-macrophage colony-stimulating factor promotes megakaryocyte maturation in nonhuman primates.
- Interim results of a multicenter trial to prevent cytomegalovirus pneumonia after allogeneic bone marrow transplantation.
- Preliminary results of a multicenter trial to prevent death from cytomegalovirus pneumonia with intravenous immunoglobulin after allogeneic bone marrow transplantation.
- Phase II study of amsacrine gluconate in refractory leukemia.
- Clostridium difficile. Colonization and toxin production in a cohort of patients with malignant hematologic disorders.
- Influence of quantity of granulocytes transfused on response.
- Transferrin in disease. I: A potential prognostic indicator in patients undergoing bone marrow transplantation.
- A randomized comparison of postremission therapy in acute myelogenous leukemia: a Southeastern Cancer Study Group trial.
- Studies of an improved rhesus hematopoietic progenitor cell assay.
- Effect of recombinant human interleukin-6 (rhIL-6) and rhIL-3 on hematopoietic regeneration as demonstrated in a nonhuman primate chemotherapy model.
- Hematologic and virologic effects of lineage-specific and non-lineage-specific recombinant human and rhesus cytokines in a cohort of SIVmac239-infected macaques.
- CD34+ and CFU-GM progenitors are significantly decreased in SIVsmm9 infected rhesus macaques with minimal evidence of direct viral infection by polymerase chain reaction.
- Peripheral blood stem cell acquisition by large-volume leukapheresis in growth factor-stimulated and unstimulated rhesus monkeys: development of an animal model.
- The ontogeny of a 57-Kd cationic antimicrobial protein of human polymorphonuclear leukocytes: localization to a novel granule population.
- Preclinical studies on deoxycoformycin and deoxyadenosine as pharmacologic T cell purging tools.
- Granulocyte colony-stimulating factor: a new approach in the treatment of childhood neutropenia.
- Chemotherapy-induced hemolytic uremic syndrome: description of a potential animal model.
- Modulation of retinoic acid-induced differentiation of human leukemia (HL-60) cells by serum factors and sphinganine.
- Large granular lymphocyte proliferation: an analysis of T-cell receptor gene arrangement and expression and the effect of in vitro culture with inducing agents.
- Leukemia of non-T lineage natural killer cells.
- Granulocyte/macrophage colony-stimulating factor primes human neutrophils for increased diacylglycerol generation in response to chemoattractant.
- Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells.
- Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell lines.
- Effects of recombinant human granulocyte-macrophage colony-stimulating factor on platelet survival and activation using a nonhuman primate model.
- Improved staining method for the simultaneous flow cytofluorometric analysis of DNA content, S-phase fraction, and surface phenotype using single laser instrumentation.
- Transient bone marrow aplasia associated with non-A, non-B hepatitis.
- A randomized trial comparing ketoconazole and nystatin prophylactic therapy in neutropenic patients.
- The clonogenic assay as a reproducible in vitro system to study predictive parameters of treatment outcome in acute nonlymphoblastic leukemia.
- Phase I multicenter trial of interleukin 6 therapy after autologous bone marrow transplantation in advanced breast cancer.
- Amsacrine in refractory adult acute leukemia: a pilot study of the Southeastern Cancer Study Group.
- Phase I trial of dianhydrogalactitol administered Iv in a weekly schedule.
- Intensive chemotherapy with daunorubicin, 5-azacytidine, 6-thioguanine, and cytarabine (DATA) for the blastic transformation of chronic granulocytic leukemia.
- Risk factors for cytomegalovirus pneumonia following allogeneic bone marrow transplantation after prophylaxis with intravenous immunoglobulin.
- Treatment of patients with acute nonlymphocytic leukemia in relapse: a Leukemia Intergroup study.
- Vancomycin-resistant Aureobacterium species cellulitis and bacteremia in a patient with acute myelogenous leukemia.
- Differential effects of long-chain (sphingoid) bases on the monocytic differentiation of human leukemia (HL-60) cells induced by phorbol esters, 1 alpha, 25-dihydroxyv...
- Therapeutic activity of 1-beta-D-arabinofuranosylcytosine conjugates of lipids in WEHI-3B leukemia in mice.
- Phase II clinical trial of carboplatin in relapsed and refractory leukemia.
- Randomized trial of high-dose cytarabine versus amsacrine in acute myelogenous leukemia in relapse: a Leukemia Intergroup Study.
- Sequentially administered 5-azacitidine and amsacrine in refractory adult acute leukemia: a phase I-II trial of the Southeastern Cancer Study Group.
- Factors affecting survival in allogeneic bone marrow transplantation.
- Prediction of response of acute nonlymphocytic leukaemia to therapy with ''high dose'' cytosine arabinoside.
- Therapy of acute myelogenous leukemia in patients over the age of 50: a randomized Southeastern Cancer Study Group trial.
- Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma.
- High-dose cytosine arabinoside and daunorubicin as primary therapy in elderly patients with acute myelogenous leukemia. A phase I-II study of the Southeastern Cancer S...
- Reverse transcriptase-polymerase chain reaction for bcr/abl fusion in chronic myelogenous leukemia.
- Cytokine upregulation of the antigen presenting function of acute myeloid leukemia cells.
- Ophthalmological and other toxicities related to cytosine arabinoside and total body irradiation as preparative regimen for bone marrow transplantation.
- Association of busulfan area under the curve with veno-occlusive disease following BMT.
- Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell tra...
- Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphami...
- Autologous bone marrow transplantation in acute leukemia with marrow purged with alkyl-lysophospholipid.
- CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs.
- High dose cyclophosphamide, fractionated total body irradiation with involved field irradiation and autologous bone marrow transplantation in malignant lymphoma.
- The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versu...
- High dose chemotherapy without hematopoietic cell support for the treatment of refractory lymphoma.
- Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
- Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of ...
- Spectrum of FDG PET/CT findings in Burkitt lymphoma.
- Prognostic significance of leukopenia at the time of diagnosis in acute myeloid leukemia.
- High-dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years.
- Does pretreatment fluorescence in situ hybridization for BCR-ABL predict imatinib-associated hematologic toxicity in chronic myeloid leukemia?
- Peripheral blood monitoring of chronic myeloid leukemia during treatment with imatinib, second-line agents, and beyond.
- Phase II study of obatoclax mesylate (GX15-070), a small-molecule BCL-2 family antagonist, for patients with myelofibrosis.
- A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis.
- Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters.
Schools
University Of ChicagoThe Pritzker School Of Medicine
University of Chicago
Emory University School Of Med
Doctors Specialties
- Internal Medicine
- Hematology
Accepted Insurances
Education
-
Emory University -
University of Chicago -
University of Chicago Pritzker School of Medicine
Hospital
-
Emory University Hospital -
Grady Memorial Hospital -
Emory University Hospital Midtown
Drug Facts
| NPI NUMBER | 1659489235 | |
| NPPES Provider LastName | WINTON | |
| NPPES Provider FirstName | ELLIOTT | |
| NPPES Provider ZIPCode | 303221013 | |
| NPPES Provider State | GA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 1250.0 | |
| Distinct Opioid Count | 5.0 | |
| Opioid Claim Count | 108.0 | |
| Percent Opioid Claims | 8.64 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1659489235 |
| Last Name Of The Provider | WINTON |
| First Name Of The Provider | ELLIOTT |
| View All |
Similar Doctors
|
|
Dr. Joseph H. Martin Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fisseha Z. Bekele, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachel A. Schonberger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles R. Harper, MD |
|
|
Dr. Morgan L. McLemore, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ana G. Antun, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ngoc H. Gunter, MD |
|
|
Dr. Fuad El Rassi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard S. Leff, MD |
|
|
Dr. David Brodeur, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janice A. Galleshaw, MD
This Doctor is OpenDoctor Recommended.
|